31/10/2024  17:35:29 Var. -0.0750 Volume Denaro18:02:14 Lettera18:02:14 Capitalizzazione di mercato Dividend Y. Rapporto P/E
10.2450EUR -0.73% 1.77 mill.
Fatturato: 18.08 mill.
10.2450Quantità in denaro: 400 10.3000Quantità in lettera: 185 8.64 bill.EUR - 113.83

Descrizione business

Grifols S.A., headquartered in Barcelona, Spain, is a global healthcare company with a track-record of more than 75 years improving people’s health and well-being through the development of plasma protein therapies, hospital pharmacy products and diagnostic technology for clinical use. They have three primary divisions: Bioscience, Diagnostic and Hospital. The company is present in more than 100 countries worldwide and its headquarters are located in Barcelona, Spain. Grifols is a leader in plasma collection with a network of 160 plasma donation centers in the U.S., and is a leading producer of plasma-derived medicines. As a recognized leader in transfusion medicine, Grifols offers a comprehensive range of transfusion medicine, hemostasis, and immunoassay solutions for clinical laboratories, blood banks, and transfusion centers.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Nacho Abia
Consiglio di amministrazione
Raimon Grífols Roura, Víctor Grífols Deu, Thomas Glanzmann
Consiglio di sorveglianza
Belén Villalonga Morenés, Carina Szpilka Lázaro, Enrique Felip Font, Iñigo Sánchez- Asiaín Mardones, James Costos, Marla E.Salmon, Raimon Grífols Roura, Ramon Riera Roca, Steven F. Mayer, Tomás Dagá Gelabert, Víctor Grífols Deu, Víctor Grifols Roura
 

Dati aziendali

Name: Grifols S.A.
Indirizzo: Avinguda de la Generalitat, 152, Parque empresarial Can Sant Joan,ES-08174 Sant Cugat del Vallès, Barcelona
Telefono: +34-93-5712200
Fax: +34-93-5710267
E-mail: grifols@grifols.com
Internet: www.grifols.com
Industria: Healthcare
Settore: Medical Products
Sub settore: Medical Supplies
Fine dell'anno finanziario: 31/12
Flottante libero: 100.00%
Data dell'IPO: -

Rapporti con gli investitori

Name: -
IR telefono: +34-93-5710221
IR Fax: +34-93-5712201
IR e-mail: inversores@grifols.com

Principali azionisti

FreeFloat
 
100.00%